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ABSTRACT:   
   
This is a case report of a 55- year old male patient who presented with features of intestinal obstruction. 
The obstruction which was relieved surgically by removal of fibrous adhesions was found to be the result 
of Pseudomyxoma peritonei however, at operation the primary focus of the tumor was not found because of 
extensive local metastasis. The patient received parental chemotherapy inform of intravenous 5-fluorouracil 
(6oomg/day 5 times/ week) for 6 month and was discharged from hospital in good condition.   
 
 
INTRODUCTION   
Pseudomyxoma peritonei syndrome first described by Karl F. Rokilansky in 1842 is often a fatal intra - 
abdominal disease (1) .Characterized by mucinous ascites and mucinous tumor disseminated on peritoneal 
surface; the disease almost always originated from a perforated appendiceal epithelial tumor. 
Histopathologic assessment of aggressive versus non invasive character of the mucinous tumor has been 
shown to have an impact on the survival of patients treated with  cytoreductive surgery and intraperitoneal 
chemotherapy (2) .The syndrome associated with repeated mucocele, cysadenoma, and low grade carcinoma 
arising from appendix, ovaries or colon and rare in pleural cavity (3) . Metastasis and extra peritoneal 
involvement are extremely rare events (4).    
The operative morbidity and mortality are null. The global 5- year s survival rate is 60% (100% in benign 
diseases and 0% in malignant form. The syndrome is  still poorely understood. The origin of the disease is 
appendix (70-80%) and less frequency the ovary (5, 6)   .   
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Acute appendicitis is the common presentation 27%. For women the diagnosis was most commonly made 
while being evaluated for an ovarian mass 39%. Increasingly abdominal girth was the second most common 
presentation overall 23%, 14% presented with new onset hernia, of which the majorities were inguinal hernia     
(7, 8)     .   
The morbidity of treated patients 27% and the mortality is 2.7% (9). Morbidity is principally related to 
mechanical complications due to ascitis and characteristic of the groups of the secretary cells   (10).   
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Abdominal ultrasonography, computer tomography and laparoscopy are of significance in the diagnosis of 
this disease which is yet confirmed usually during surgery. The treatment is principally surgical, the result 
of chemotherapy are modest .The disease has slow course and is susceptible to recurrence   (11).   
CASE PRESENTATION:   
A 55 year old male patient was admitted to hospital because of gradual onset abdominal distension, absolute 
constipation & persistent vomiting 3 weeks prior to admission.  His condition was not associated with any 
febrile illness.  He lost weight despite a good appetite. He has no past history of tuberculosis, intestinal 
schistosomiasis or chronic diarrhea. He was alcoholic and cigarette smoker for the last ten years. Clinical 
examination revealed a cachexic patient with pallor and gross finger clubbing. The cardiovascular and 
respiratory systems were normal; however the abdomen was distended with full flanks and multiple 
abdominal masses. The provisional diagnosis was of intestinal obstruction. Investigations done revealed the 
following:  Hb 8.8 gram/dl, WBC 2100/cml, E.S.R.  110 ml/h, Liver function test, ECG, upper G.I.T 
Endoscopy and chest X- ray were normal. Ultrasound of the abdomen showed a cirrhotic liver, enlarged 
paraaortic lymph gland. I.C.T. for tuberculosis was negative. Plain x-ray abdomen showed distended loops 
of small bowel.   
The patient was managed initially conservatively i.e.:  nothing by mouth, nasogastric suction, l.V. fluids, 
ceftriaxone 1 gm I.V. daily and metronidazole infusion.  Laparotomy was done 2 days later. The findings at 
Laparotomy were of mucinous containing masses in the sheets of peritoneum with massive adhesions & 
distended small bowel loops. The transverse colon was fixed to the anterior abdominal wall  frozen 
abdomen. Fibrous adhesions were relived.  No primary lesion can be found at operation. A biopsy was taken. 
The result of the biopsy showed mainly mucous, mucoid material with scanty abnormal cells, consistent 
with Pseudomyxoma peritonei. The patient received 5 fluorouracil intravenously (6oomg/day 5 times/ week) 
for 6 months and was discharged from the hospital in good condition.    
DISCUSSION   
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Pseudomyxoma peritonei occurs more frequently in females. The abdomen is filled with a yellow Jelly, 
large quantities which are often more or less encysted. The condition is associated with mucinous cystic 
tumors of ovaries and appendix. The condition arises in one of 2 ways either from a mucocle of the appendix 
or rupture of pseudomucinous cyst of the ovaries.    
It is often painless and there is no impairment of general health for a long time. When the condition arises 
from the appendix the mass is often more localized but in cases of ovarian origin the whole peritoneal cavity 
is involved. Although the abdomen is distended with what seems to be fluid that cannot be made to shift 
should suggest the possibility. It is highly improbable that a correct preoperative diagnosis will be made. At 
Laparotomy masses of Jelly are scooped out and the primary focus if can be found is removed. Unfortunately 
recurrence is usual.   
Occasionally the condition responds to radioactive istopes which should certainly be employed in recurrent 
cases. Interferon has been used in the treatment of this condition (12).   
Recent advances in treatment of pseudomyxoma peritonei included extensive surgery with direct 
administration of selected drugs into the periotoneal cavity.  This permits delivery of high concentrations of 
drugs directly to abdominal and pelvic surfaces where the tumor is located.  This pharmacological advantage 
is the result of the peritoneum  plasma barrier.  A major problem in the past with intraperitoneal 
chemotherapy delivery involved non-uniform drug distribution.  This resulted from intestinal adhesions, 
from tissues closed off by sutures, and from pooling of inraperitoneal fluid at dependent sites.  The use of 
heated intraoperative intraperitoneal chemotherapy (HIIC) after complete dissection of an adhesive process 
and before anastomoses are completed minimizes the problem. It does not only improve drug distribution 
but also improves the drug penetration into tissue compared to normothermic drug administration.  Common 
drugs which are in use include mitomycin, 5 fluorouracil and leucovorin (13).           
CONCLUSION:   
Pseudomyxoma peritonei is a locally malignant tumor; preoperative diagnosis is unlikely to be established. 
In our patient the diagnosis was established at lapratomy. The obstruction was relieved surgically and the 
patient received 5 fluorouracil posts operatively. His general condition improved and he was discharged 
from the hospital in good condition.   
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